Data completeness
1/8 — Limited
CLISTIN (carbinoxamine maleate) by Johnson & Johnson is mechanism of actions carbinoxamine maleate, an ethanolamine derivative, is an antihistamine with anticholinergic (drying) and sedative properties.
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CLISTIN (carbinoxamine maleate) is an oral antihistamine elixir derived from the ethanolamine class, used to treat allergic conditions and related symptoms. It works by competing with histamine at H1 receptor sites on effector cells throughout the gastrointestinal tract, blood vessels, and respiratory tract. The drug carries anticholinergic and sedative properties typical of first-generation antihistamines.
Pre-Launch
Pre-launch stage indicates emerging commercial infrastructure requirements; team buildout and launch planning will drive near-term hiring.
Mechanism of Action
Mechanism of Actions Carbinoxamine maleate, an ethanolamine derivative, is an antihistamine with anticholinergic (drying) and sedative properties. Carbinoxamine appears to compete with histamine (type H1) for receptor sites on effector cells in the gastrointestinal tract, blood vessels and…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CLISTIN is currently in pre-launch phase with no active job postings; however, Johnson & Johnson's backing suggests significant commercial investment upon approval. Professionals joining this product will participate in a launch-phase initiative with opportunities to build market presence in the competitive antihistamine category.
Brand Manager
Worked on CLISTIN at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.